BEST OF - Rapamycin As A Longevity Drug - podcast episode cover

BEST OF - Rapamycin As A Longevity Drug

Oct 18, 201958 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

SHR # 2416 :: BEST OF - Rapamycin As A Longevity Drug - Dr. Mikhail Blagosklonny - This show first aired in May 2010. No one had rapamycin or the mTOR/AMPK pathways to reverse senescent cells on their radars yet. Rapamycin may represent the the first "longevity and anti-aging drug" that will be marketed by the Pharmaceutical Industry. When you listen to the interview you'll realize that it may reduce the occurrences of ALL the chronic diseases that are ravaging our population while extending life up to 30%.
For the best experience, listen in Metacast app for iOS or Android